Richard A Md Miller Corvus Pharmaceuticals, Inc. (CRVS) insider trading activity

Richard A Md Miller is President and CEO of Corvus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.14 Million shares of CRVS, which is worth approximately $4.5 Million. The most recent transaction as insider was on May 07, 2025, when has been sold 559,073 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $1,956,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M

96.79% 3M change

96.79% 12M change

Total Value Held $4.5 Million

RICHARD A MD MILLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2025	BUY Exercise of conversion of derivative security	$1,956,755 $3.5 p/Share	559,073 Added 32.97%	1,136,707 Common Stock
May 06 2024	BUY Open market or private purchase	$999,306 $1.73 p/Share	577,634 Added 50.0%	577,634 Common Stock
May 04 2021	BUY Open market or private purchase	$99,999 $2.8 p/Share	35,714 Added 50.0%	35,714 Common Stock

Also insider at

BOLT

Bolt Biotherapeutics, Inc. Healthcare

Director

RAM